PSBQ yields 2.45% · ABBV yields 3.06%● Live data
📍 PSBQ pulled ahead of the other in Year 4
Combined, PSBQ + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PSBQ + ABBV for your $10,000?
PSB Holdings, Inc. operates as the holding company for Peoples State Bank that provides a range of retail consumer and commercial banking products and services to individuals and businesses. The company offers checking, savings, individual retirement, and money market accounts, as well as certificates of deposit; and certificate of deposit account registry services. It also provides debit, prepaid, and credit cards; fixed and adjustable rate mortgages; guaranteed rural housing, veterans administration, federal housing administration, construction, land, auto, personal, and student loans; home equity line of credit and loans; overdrafts; business lines of credit, equipment financing, healthcare specialty lending, small business administration loans, and business real estate financing; and business acquisition and buy-outs, and cash management services. In addition, the company offers private banking services; e-statements; investment and insurance products; commercial treasury management services; sweeps and zero balance accounts; and online bill pay, fraud protection, automated clearing house, on-site deposit, and merchant services, as well as online and mobile banking services. As of January 28, 2022, it operated ten full-service banking locations in Marathon, Oneida, Vilas, Milwaukee, and Waukesha counties, Wisconsin; and a loan production office in Stevens Point, Wisconsin. The company was founded in 1962 and is headquartered in Wausau, Wisconsin.
Full PSBQ Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.